Renal Cancer Panel
ATTENTION: This test is being retired. The last day to order this test is September 16, 2025. Samples must be received by September 30, 2025, or your order will be canceled.
New York
Approved
Genes
Conditions
- Renal Cancer
Clinical Utility
- A personal or family history of renal cancer at a young age (i.e. ≤46 years)
- A personal or family history of bilateral renal cancer (disease in both kidneys) or multiple primary tumors in a single kidney
- Multiple renal cancers within a family
- A pattern of cancer in which the individuals with similar or related cancers (see table below) are on one side of the family spanning multiple generations
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Test Code
B394
CPT Codes*
81435x1
ABN Required
No
Turnaround Time**
3 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing